Exact Sciences Corp [NASDAQ: EXAS] plunged by -$3.31 during the normal trading session on while it closed the day at $43.04.
Exact Sciences Corp stock has also loss -7.72% of its value over the past 7 days. However, EXAS stock has declined by -30.36% in the 3 months of the year. Over the past six months meanwhile, it has lost -26.28% and lost -23.40% year-on date.
The market cap for EXAS stock reached $7.99 billion, with 185.62 million shares outstanding and 183.01 million shares in the current float. Compared to the average trading volume of 2.17M shares, EXAS reached a trading volume of 3356542 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Exact Sciences Corp [EXAS]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for EXAS shares is $70.18 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on EXAS stock is a recommendation set at 1.43. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
RBC Capital Mkts have made an estimate for Exact Sciences Corp shares, keeping their opinion on the stock as Sector Perform, with their previous recommendation back on Mar-14-25. While these analysts kept the previous recommendation, Barclays raised their target price to Overweight. The new note on the price target was released on January 23, 2025, representing the official price target for Exact Sciences Corp stock. Previously, the target price had yet another raise to $75, while Wells Fargo analysts kept a Overweight rating on EXAS stock.
The Average True Range (ATR) for Exact Sciences Corp is set at 2.46, with the Price to Sales ratio for EXAS stock in the period of the last 12 months amounting to 2.90. The Price to Book ratio for the last quarter was 3.33, with the Price to Cash per share for the same quarter was set at 5.59. Price to Free Cash Flow for EXAS in the course of the last twelve months was 107.24 with Quick ratio for the last quarter at 1.92.
EXAS stock trade performance evaluation
Exact Sciences Corp [EXAS] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -7.72. With this latest performance, EXAS shares dropped by -15.71% in over the last four-week period, additionally sinking by -26.28% over the last 6 months – not to mention a drop of -29.09% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for EXAS stock in for the last two-week period is set at 29.30, with the RSI for the last a single of trading hit 26.35, and the three-weeks RSI is set at 32.03 for Exact Sciences Corp [EXAS]. The present Moving Average for the last 50 days of trading for this stock 52.21, while it was recorded at 45.46 for the last single week of trading, and 55.72 for the last 200 days.
Exact Sciences Corp [EXAS]: An insightful look at the core fundamentals
Exact Sciences Corp’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.92 and a Current Ratio set at 2.15.
Exact Sciences Corp [EXAS]: Institutional Ownership
There are presently around $100.73%, or 101.82%% of EXAS stock, in the hands of institutional investors. The top three institutional holders of EXAS stocks are: VANGUARD GROUP INC with ownership of 18.18 million shares, which is approximately 9.9672%. CAPITAL WORLD INVESTORS, holding 16.5 million shares of the stock with an approximate value of $$697.18 million in EXAS stocks shares; and CAPITAL WORLD INVESTORS, currently with $$624.81 million in EXAS stock with ownership which is approximately 8.1099%.
